Home › Long COVID › Michigan › Warren
Long COVID clinical trials in Warren, MI
3 studies for Long COVID are looking for participants at sites in and around Warren (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
RecruitingPhase 3
- Henry Ford St John TM Center for Infectious Disease Research ( Site 3766), Grosse Pointe Woods · 6 mi away
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RecruitingPhase 3
- Research Site, Royal Oak · 7 mi away
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RecruitingPhase 3
- Henry Ford St. John Hospital, Grosse Pointe Woods · 6 mi away
About Long COVID
Anyone who has had COVID-19 can have long-lasting symptoms, know as long COVID. Learn about the symptoms and how to manage them, diagnosis, and prevention.
More about Long COVID on MedlinePlus
Long COVID trials in other cities
- New York City, NY17 studies
- Houston, TX14 studies
- Chicago, IL12 studies
- Washington, DC12 studies
- Boston, MA11 studies
- Baltimore, MD11 studies
- Hialeah, FL8 studies
- Durham, NC8 studies
- San Francisco, CA8 studies
- Atlanta, GA7 studies
- San Diego, CA7 studies
- Miami, FL7 studies
Other studies in Warren
- Breast Cancer9 studies
- Prostate Cancer7 studies
- Coronary Artery Disease6 studies
- Bladder Cancer6 studies
- Lung Cancer6 studies
- Cancer (all types)5 studies
- Colorectal Cancer5 studies
- Ovarian Cancer4 studies
- Aortic Valve Stenosis4 studies
- Non-Small Cell Lung Cancer4 studies
- Multiple Myeloma3 studies
- Burkitt Lymphoma3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.